chr15-57438393-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032866.5(CGNL1):āc.394C>Gā(p.Arg132Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000336 in 1,614,034 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032866.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CGNL1 | NM_032866.5 | c.394C>G | p.Arg132Gly | missense_variant | 2/19 | ENST00000281282.6 | NP_116255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CGNL1 | ENST00000281282.6 | c.394C>G | p.Arg132Gly | missense_variant | 2/19 | 1 | NM_032866.5 | ENSP00000281282.5 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251160Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135812
GnomAD4 exome AF: 0.000352 AC: 515AN: 1461880Hom.: 1 Cov.: 33 AF XY: 0.000331 AC XY: 241AN XY: 727244
GnomAD4 genome AF: 0.000177 AC: 27AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 08, 2023 | The c.394C>G (p.R132G) alteration is located in exon 2 (coding exon 1) of the CGNL1 gene. This alteration results from a C to G substitution at nucleotide position 394, causing the arginine (R) at amino acid position 132 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at